Inappropriate prescribing in elderly people with diabetes admitted to hospital

Diabetic Medicine

Volumn 33, Issue 5, 2016, Pages 655-662

  Formiga, F ^a,b   Vidal, X ^c,d   Agusti A ^c,d   Chivite, D ^a,b   Roson B ^a   Barbe J ^b,c,d   Lopez Soto A ^b,e   Torres, O H ^b,d   Fernandez Moyano A ^b,f   Garcia J ^b,g   Ramirez Duque N ^b,h   San Jose A ^b,c,d  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Multimorbidity and Elderly Patients Group of the Spanish Society of Internal Medicine   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f HOSPITAL SAN JUAN DE DIOS DEL ALJARAFE   (Spain)

^g HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROPAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FERROUS SULFATE; GLIBENCLAMIDE; INSULIN GLARGINE; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; ORAL ANTIDIABETIC AGENT;

AGED; AGING; ARTHRALGIA; ARTICLE; ASSESSING CARE OF VULNERABLE ELDERS; ASSESSMENT OF HUMANS; ATRIAL FIBRILLATION; BARTHEL INDEX; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; INAPPROPRIATE PRESCRIBING; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRESCRIPTION; PREVALENCE; PROSPECTIVE STUDY; PROTEINURIA; RISK FACTOR; SCREENING TOOL OF OLDER PERSON PRESCRIPTIONS; SCREENING TOOL TO ALERT DOCTORS TO RIGHT TREATMENT CRITERIA; VERY ELDERLY; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; COMPLICATION; DEVELOPED COUNTRY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORD; HOSPITALIZATION; INTERNAL MEDICINE; MEDICATION THERAPY MANAGEMENT; POLYPHARMACY; PRIMARY HEALTH CARE; SPAIN;

AGED; AGED, 80 AND OVER; AGING; COHORT STUDIES; COMORBIDITY; DEVELOPED COUNTRIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITALIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; INTERNAL MEDICINE; MALE; MEDICATION RECONCILIATION; POLYPHARMACY; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; SPAIN;

EID: 84951196798     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12894     Document Type: Article

References (33)

1. Selvin E, Coresh J, Brancati FL. The burden and treatment of diabetes in elderly individuals in the U.S. Diabetes Care 2006; 29: 2415-2419.
2. Soriguer F, Goday A, Bosch-Comas A, Bordiu E, Calle-Pascual A, Carmena R et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es study. Diabetologia 2012; 55: 88-93.
3. Ferrer A, Padrós G, Formiga F, Rojas-Farreras S, Perez JM, Pujol R. Diabetes mellitus: prevalence and effect of morbidities in the oldest old. The Octabaix study. J Am Geriatr Soc 2012; 60: 462-467.
4. Formiga F, Ferrer A, Sanz H, Marengoni A, Alburquerque J, Pujol R. Octabaix study members. Patterns of comorbidity and multimorbidity in the oldest old: the Octabaix study. Eur J Intern Med 2013; 24: 40-44.
5. Caughey GE, Roughead EE, Vitry AI, McDermott RA, Shakib S, Gilbert AL. Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts. Diabetes Res Clin Pract 2010; 87: 385-393.
6. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing in older people. J Am Geriatr Soc 2006; 54: 1516-1523.
7. Budnitz D, Sehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug event in older adults. Ann Intern Med 2007; 147: 755-765.
8. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA 1998; 279: 1200-1205.
9. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA 2005; 294: 716-724.
10. Chang CB, Chen JH, Wen CJ, Kuo HK, Lu IS, Chiu LS et al. Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. Br J Clin Pharmacol 2011; 72: 482-489.
11. Dimitrow MS, Airaksinen MS, Kivelä SL, Lyles A, Leikola SN. Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individual aged 65 and older: a systematic review. J Am Geriatr Soc 2011; 59: 1521-1530.
12. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers Criteria for potentially inappropriate medication use in older adults. Arch Intern Med 2003; 163: 2716-2724.
13. American Geriatrics Society 2012 Beers Criteria Update expert panel. American Geriatics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60: 616-631.
14. Gallagher PF, O'Mahony D. STOPP (Screening Tool of Older Persons' Potentially Inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008; 37: 673-679.
15. Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I et al. AdHOC Project Research Group. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293: 1348-1358.
16. Gallagher P, Lang PO, Cherubini A, Topinková E, Cruz-Jentoft A, Montero Errasquín B et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol 2011; 67: 1175-1188.
17. Barry PJ, Gallagher PF, Ryan C, O'Mahony D. START (Screening Tool to Alert Doctors to the Right Treatment) - an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007; 36: 632-638.
18. San-José A, Agustí A, Vidal X, Formiga F, López-Soto A, Fernández-Moyano A et al. on behalf of Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators' Project. Inappropriate prescribing to older patients admitted to hospital: a comparison of different tools of misprescribing and underprescribing. Eur J Intern Med 2014; 25: 710-716.
19. San-José A, Agustí A, Vidal X, Barbé J, Torres OH, Ramírez-Duque N et al. Potentially Inappropriate Prescribing in Older Patients in Spain (PIPOPS) Investigators' project. An inter-rater reliability study of the prescribing indicated medications quality indicators of the Assessing Care of Vulnerable Elders (ACOVE) 3 criteria as a potentially inappropriate prescribing tool. Arch Gerontol Geriatr 2014; 58: 460-464.
20. Wenger NS, Roth CP, Shekelle P, the ACOVE investigators. Introduction to the Assessing Care of Vulnerable Elders 3 quality indicators measurement set. J Am Geriatr Soc 2007; 55: S247-S252.
21. Assessing Care of Vulnerable. Elders-3 quality indicators. J Am Geriatr Soc 2007; 55: S464-S487.
22. Gallagher P, Baeyens JP, Topinkova E, Madlova P, Cherubini A, Gasperini B et al. Inter-rater reliability of STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment) criteria amongst physicians in six European countries. Age Ageing 2009; 38: 603-606.
23. Bauer S, Nauck MA. Polypharmacy in people with Type 1 and Type 2 diabetes is justified by current guidelines - a comprehensive assessment of drug prescriptions in patients needing inpatient treatment for diabetes-associated problems. Diabet Med 2014; 31: 1078-1085.
24. Peron EP, Ogbonna KC, Donohoe KL. Antidiabetic medications and polypharmacy. Clin Geriatr Med 2015; 31: 17-27.
25. Gómez Huelgas R, Díez-Espino J, Formiga F, Lafita Tejedor J, Rodríguez Mañas L et al. en nombre del Grupo de Trabajo para el Documento de Consenso sobre el tratamiento de la diabetes tipo 2 en el anciano. [Treatment of type 2 diabetes in the elderly]. Med Clin (Barc) 2013; 140: 134.e1-e134.
26. Formiga F, Duaso E, Ruiz D. San José A, Urrutia A, López-Soto A. Use of benzodiazepines according to the admission diagnosis. Med Clin (Barc) 2012; 139: 531-534.
27. O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015; 44: 213-218.
28. Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis 2005; 46: 1080-1087.
29. Formiga F, Ferrer A, Mimbrera D, Badia T, Fernández C, Pujol R. Grupo de Estudio Octabaix. High rate of anticoagulation therapy in oldest old subjects with atrial fibrillation: the Octabaix study. J Am Med Dir Assoc 2012; 13: 8-10.
30. Martinez-Laguna D, Tebe C, Javaid MK, Nogues X, Arden NK, Cooper C et al. Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study. Osteoporos Int 2015; 26: 827-833.
31. Vinik AI, Vinik EJ, Colberg SR, Morrison S. Falls risk in older adults with type 2 diabetes. Clin Geriatr Med 2015; 31: 89-99.
32. McBride JE, Pater JL, Dorland JL, Lam YM. Extent and variation of omeprazole prescribing in an elderly population of Ontario. Ann Pharmacother 1997; 31: 411-416.
33. Kjeldsen LJ, Bjerrum L, Dam P, Larsen BO, Rossing C, Søndergaard B, Herborg H. Safe and effective use of medicines for patients with type 2 diabetes - a randomized controlled trial of two interventions delivered by local pharmacies. Res Social Adm Pharm 2015; 11: 47-62.